Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3030% below fair value
$59.56−1.79 (-2.92%)
Close on Nov 18, 2026Market cap $121.75BP/E 13.2Yield 4.18%
Bristol Myers Squibb price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bristol Myers Squibb's price to sales ratio was 2.6× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 1.8× to 3.7×, with a median of 2.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | +0.3 |
| 2025 | Dec 31, 2025 | 2.3× | −0.1 |
| 2024 | Dec 31, 2024 | 2.4× | +0.0 |
| 2023 | Dec 29, 2023 | 2.4× | −0.9 |
| 2022 | Dec 30, 2022 | 3.3× | +0.3 |
| 2021 | Dec 31, 2021 | 3.1× | −0.4 |
| 2020 | Dec 31, 2020 | 3.4× | −0.9 |
| 2019 | Dec 31, 2019 | 4.3× | +0.5 |
| 2018 | Dec 31, 2018 | 3.9× | −1.1 |
| 2017 | Dec 29, 2017 | 5.0× | −0.4 |
| 2016 | Dec 30, 2016 | 5.3× | −1.6 |
| 2015 | Dec 31, 2015 | 7.0× | +0.8 |
| 2014 | Dec 31, 2014 | 6.1× | +0.7 |
| 2013 | Dec 31, 2013 | 5.5× | +2.5 |
| 2012 | Dec 31, 2012 | 2.9× | +0.0 |
| 2011 | Dec 30, 2011 | 2.9× | – |
See a number that looks wrong?